Dana Turcotte
ARTICLES BY THIS AUTHOR
- 9/26/2023
Gabapentinoids for chronic pain unexpected benefits or added risk?
Evidence suggests that the harms of gabapentinoid misuse may be greater than originally appreciated. Overuse has been associated with an increase in all-cause hospitalizations, a risk that was found to be three times higher in those concurrently taking high-dose opioids. - 4/6/2023
Cannabis: Is pain management for the elderly going plant-based?
In more than four years’ experience with cannabis legalization in Canada, one thing has become patently clear—Canadians have bought into (and are buying lots of) cannabis. - 2/3/2023
Escaping the daily grind: Non-oral buprenorphine options for opioid use disorder management
Alternatives to daily dosing are making their way to the forefront of OUD care. - 6/13/2022
Navigating painful decisions: Pain management in older adults
Factors such as altered drug absorption and decreased clearance due to impaired renal or hepatic activity can significantly affect how drugs will behave with use. - 4/22/2022
Good in a crisis: pharmacists’ roles in opioid stewardship
Year to year, Canada consistently ranks second or third in the world for per capita opioid consumption. - 10/8/2021
Pain and the pandemic
From delayed diagnoses and fragmented healthcare to skyrocketing suicide rates and opioid overdoses, the isolation of lockdowns will undoubtedly have negative ripple effects for the foreseeable future.
